Swain, S. 2017. 2-hour 75 gm OGTT for screening and Rescreening at 32-34 weeks for diagnosing gestational diabetes-evaluation of maternal and neonatal outcomes. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 6, 7 (Jun. 2017), 2926–2932. DOI:https://doi.org/10.18203/2320-1770.ijrcog20172909.